Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2006

View Archived Issues

Study data reveal analgesic profile of tapentadol

RN-624 relieves pain from knee osteoarthritis

Hm-E16: potential monoclonal antibody treatment for neuro-invasive WNV

Merck Sharp and Dohme presents novel NK-1R antagonists

MARINA reveals ranibizumab safety, quality of life impact in macular degeneration

DNA repair seen in reconstructed skin with liposome-encapsulated T4 endonuclease V

Lenalidomide effective in cutaneous T-cell lymphoma: preliminary phase II results

AstraZeneca rounds up recent developments

Medivir presents summary of quarterly activities

CHI-033: a new selective inhibitor of Coxsackie B viral replication

Rac1 GTPase a novel antiplatelet target for the management of thrombosis

YM Biosciences completes Eximias acquisition

Advexin p53 therapy shows utility for Li-Fraumeni syndrome

CYT-500 cleared for first U.S. phase I study

Trial studies SIR-Spheres with Xeloda for metastatic liver cancer

Bionovo advancing MF-101 for vasomotor symptoms

Chelsea Therapeutics begins development program for droxidopa

Ube Industries and Santen to jointly develop ROCK inhibitor DE-104

Quigley begins clinical testing of QR-333 in diabetic peripheral neuropathy

Merck & Co. to acquire GlycoFi and Abmaxis

Aradigm awarded orphan drug status for liposomal ciprofloxacin in cystic fibrosis

Immunomedics and UCB sign agreement for epratuzumab

Kissei signs agreement for anti-CD20 humanized monoclonal antibody

Otsuka launches Ozex Ophthalmic solution in Japan

Phase I results for AnGes' HGF genetic agent for ischemic heart disease

Yasminelle completes European mutual recognition procedure

Novel treatment options described for disorders of impaired metabolism

Urief launched in Japan for urinary disturbance associated with enlarged prostate

Novel antiinfective agents disclosed in recent patent literature

New therapeutic agents for asthma, COPD, etc. reported in recent patent literature

Preclinical data on novel HIF prolyl hydroxylase inhibitor reported by FibroGen

Novel antipsoriatic demonstrates efficacy in vivo

Senju reports positive preclinical data on the calpain inhibitor SNJ-1945

Bortezomib may be useful to treat retinoblastoma

Synthesis and characterization of novel dipeptidyl peptidase IV inhibitors from Pfizer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...